IL164560A0 - - Google Patents

Info

Publication number
IL164560A0
IL164560A0 IL16456004A IL16456004A IL164560A0 IL 164560 A0 IL164560 A0 IL 164560A0 IL 16456004 A IL16456004 A IL 16456004A IL 16456004 A IL16456004 A IL 16456004A IL 164560 A0 IL164560 A0 IL 164560A0
Authority
IL
Israel
Prior art keywords
modulating
enhance
methods
ultraviolet light
damage caused
Prior art date
Application number
IL16456004A
Other languages
English (en)
Original Assignee
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona filed Critical Univ Arizona
Publication of IL164560A0 publication Critical patent/IL164560A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
IL16456004A 2002-04-19 2004-10-13 IL164560A0 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37403302P 2002-04-19 2002-04-19
PCT/US2003/011842 WO2003088909A2 (en) 2002-04-19 2003-04-17 Methods for modulating phototoxicity

Publications (1)

Publication Number Publication Date
IL164560A0 true IL164560A0 (xx) 2005-12-18

Family

ID=29251125

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16456004A IL164560A0 (xx) 2002-04-19 2004-10-13
IL203968A IL203968A (en) 2002-04-19 2010-02-15 The nature of light damage to the treatment of light damage caused by UV

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL203968A IL203968A (en) 2002-04-19 2010-02-15 The nature of light damage to the treatment of light damage caused by UV

Country Status (17)

Country Link
US (3) US6992071B2 (xx)
EP (1) EP1496891B1 (xx)
JP (2) JP4527405B2 (xx)
CN (1) CN1298321C (xx)
AT (1) ATE516802T1 (xx)
AU (1) AU2003234119B2 (xx)
CA (2) CA2668311C (xx)
CY (1) CY1112194T1 (xx)
DK (1) DK1496891T3 (xx)
ES (1) ES2367258T3 (xx)
HK (1) HK1077761B (xx)
IL (2) IL164560A0 (xx)
MX (1) MXPA04010228A (xx)
NZ (1) NZ535982A (xx)
PT (1) PT1496891E (xx)
RU (1) RU2301800C2 (xx)
WO (1) WO2003088909A2 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2668311C (en) * 2002-04-19 2011-08-02 Arizona Board Of Regents, Acting On Behalf Of The University Of Arizona Enhancing photodamage caused by ultraviolet light using a 3-hydroxypyridine analog
AU2009224813A1 (en) * 2008-03-10 2009-09-17 Basf Se Encapsulated phase change materials in seed coatings
ES2638046T3 (es) * 2009-03-30 2017-10-18 Shiseido Company, Ltd. Composiciones para aliviar los daños inducidos por la radiación ultravioleta

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310461A (en) * 1980-06-23 1982-01-12 E. R. Squibb & Sons, Inc. Imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US6309440B1 (en) * 1998-08-25 2001-10-30 Thomas T. Yamashita Method and composition for promoting and controlling growth of plants
US5208249A (en) * 1992-08-20 1993-05-04 Clintec Nutrition Co. Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
JPH0797322A (ja) * 1993-09-29 1995-04-11 Shiseido Co Ltd 一重項酸素消去剤
US5681554A (en) * 1995-06-28 1997-10-28 Cosmair, Inc. Composition for treating hair and method for using the same
US6013250A (en) * 1995-06-28 2000-01-11 L'oreal S. A. Composition for treating hair against chemical and photo damage
JP2961074B2 (ja) * 1995-09-06 1999-10-12 明治製菓株式会社 光化学療法用の新生血管閉塞剤
JPH09249567A (ja) * 1996-01-12 1997-09-22 Otsuka Pharmaceut Co Ltd 医薬組成物
EP0906078B1 (en) * 1996-05-07 2003-11-12 Eric F. Bernstein Topical use of tempol in the prevention of photoaging
US20010056085A1 (en) * 1996-07-09 2001-12-27 Avner Ramu Methods of using vesicant drug formulations
AU4484997A (en) * 1996-09-18 1998-04-14 Thomas F. Brennan Compositions containing cobalamin and amino acids
AU732214C (en) * 1997-03-31 2001-10-25 Wakamoto Pharmaceutical Co., Ltd. Biphenyl derivatives and drug composition
US6103487A (en) * 1997-08-27 2000-08-15 Merck & Co., Inc. Method of treating cancer
FR2775595B1 (fr) * 1998-03-09 2000-05-05 Seppic Sa Composition synergique comprenant un compose a structure lipoaminoacide et un extrait de menuphar
JPH11255715A (ja) * 1998-03-13 1999-09-21 Kao Corp Ｎ，ｎ−ジ置換アニリン誘導体
US20020006418A1 (en) * 1998-10-13 2002-01-17 John Kung Composition to enhance permeation of topical skin agents
FR2792650B1 (fr) * 1999-04-20 2003-02-28 Oreal Equivalent de peau agee, son procede de preparation et son utilisation
KR20020023941A (ko) * 1999-04-30 2002-03-29 오베르더 왈터 산화방지성 비타민 ｂ6 유사체
US6333344B1 (en) * 1999-05-05 2001-12-25 Merck & Co. Prolines as antimicrobial agents
US20020006394A1 (en) * 2000-02-11 2002-01-17 Redmond Robert W. Photochemical tissue bonding
US6464992B2 (en) * 2000-04-14 2002-10-15 University Of Kentucky Research Foundation Topical micronutrient delivery system and uses thereof
WO2002006225A1 (fr) * 2000-07-19 2002-01-24 Kyowa Hakko Kogyo Co., Ltd. Agents de prevention ou de traitement de la dermite atopique
JP2002128651A (ja) * 2000-10-25 2002-05-09 Kose Corp 光老化抑制剤およびそれを含有することを特徴とする皮膚外用剤
CA2436300A1 (en) * 2001-02-05 2002-08-15 L. Stephen Buchanan Multi-tapered dental files
CA2668311C (en) * 2002-04-19 2011-08-02 Arizona Board Of Regents, Acting On Behalf Of The University Of Arizona Enhancing photodamage caused by ultraviolet light using a 3-hydroxypyridine analog
DE102005000868A1 (de) * 2004-10-15 2006-04-20 Henkel Kgaa Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren

Also Published As

Publication number Publication date
WO2003088909A2 (en) 2003-10-30
HK1077761A1 (en) 2006-02-24
US6992071B2 (en) 2006-01-31
RU2004133322A (ru) 2005-08-10
US20050042188A1 (en) 2005-02-24
PT1496891E (pt) 2011-09-02
MXPA04010228A (es) 2005-06-08
JP4527405B2 (ja) 2010-08-18
EP1496891A4 (en) 2009-10-21
CN1646121A (zh) 2005-07-27
JP2010163461A (ja) 2010-07-29
US7226937B2 (en) 2007-06-05
DK1496891T3 (da) 2011-10-24
US20030223941A1 (en) 2003-12-04
AU2003234119A1 (en) 2003-11-03
IL203968A (en) 2013-02-28
NZ535982A (en) 2006-10-27
ES2367258T3 (es) 2011-10-31
CN1298321C (zh) 2007-02-07
EP1496891B1 (en) 2011-07-20
US20060009416A1 (en) 2006-01-12
HK1077761B (zh) 2007-05-25
CA2668311A1 (en) 2003-10-30
CA2482320A1 (en) 2003-10-30
CA2668311C (en) 2011-08-02
CA2482320C (en) 2010-02-09
CY1112194T1 (el) 2015-12-09
JP2005534625A (ja) 2005-11-17
EP1496891A2 (en) 2005-01-19
WO2003088909A3 (en) 2004-02-12
ATE516802T1 (de) 2011-08-15
RU2301800C2 (ru) 2007-06-27
AU2003234119B2 (en) 2007-02-08
JP5244150B2 (ja) 2013-07-24
IL203968A0 (en) 2011-07-31

Similar Documents

Publication Publication Date Title
SE0203713D0 (sv) Novel compounds
BRPI0414599A (pt) pirrol-indóis substituìdos
RS20050946A (xx) Pirolodihidroizohinolini kao pde 10 inhibitori
TW200510301A (en) Novel compounds
TW200510303A (en) Novel compounds
NO20075693L (no) Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme
CY1109088T1 (el) Μεθοδος για την παρασκευη υποκατεστημενων ενωσεων 3-αρυλο-βουτυλ-αμινης
TW200407305A (en) Novel compounds
DE602004010791D1 (de) 2,5-substituiertetetrahydroisochinoline zur verwendung als 5-ht6 modulatoren
SG145694A1 (en) Novel compounds
DK1483265T3 (da) Purinderivater som kinaseinhibitorer
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
DK1485360T3 (da) Natriumkanalblokkere
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
EA200700702A1 (ru) Аналоги локсапина и способы их применения
ECSP077270A (es) Ácidos de tiazolo - naftilo
EA201270630A1 (ru) Гетероциклические сетр ингибиторы
EA200800889A1 (ru) Гексагидроциклооктилпиразольные каннабиноидные модуляторы
UA87467C2 (xx) 4-((феноксіалкіл)тіо)феноксіоцтова кислота та її аналоги$4-((феноксиалкил)тио)феноксиуксусная кислота и ее аналоги
DE60320784D1 (de) Stände zur modulierung des knochenwachstums
DE60316984D1 (de) Benzoylsulfonamide als antitumor-mittel
ATE430148T1 (de) Neue pyrrolodihydroisochinoline als pde10- inhibitoren
UY28344A1 (es) Nuevos compuestos
DE602005010258D1 (de) Behandlung von ballastwasser
IL203968A0 (en) Photodamage modulator for treating uv photodamage

Legal Events

Date Code Title Description
KB Patent renewed